New obesity drugs are in the works; food makers tried to stack nutrition panel with preferred experts

STAT's new Obesity Drug Tracker shows many copycat candidates in development, but a few novel mechanisms too.

September 12, 2023 Check out STAT+

Sponsored By

Molly Ferguson for STAT STAT+ | New obesity drugs are in the works trying to out-blockbuster Wegovy and Mounjaro STAT's new Obesity Drug Tracker shows many copycat candidates in development, but a few novel mechanisms too. By Allison DeAngelis and Elaine Chen STAT+ | FDA proposes changes to key approval pathway for medical devices, five years after promising The FDA issued new guidelines clarifying the way they plan to evaluate medical devices that go through the controversial 510(k) pathway. By Lizzy Lawrence STAT+ | Walmart may buy concierge Medicare Advantage provider ChenMed. But will it scale? Experts largely hailed Walmart's rumored acquisition of Medicare Advantage provider ChenMed as a good buy for the retail giant. By Brittany Trang Alex Hogan/STAT The food industry has tried to stack a key nutrition policy panel with its preferred experts, documents show The food industry has worked hard to get friendly researchers into a key panel of nutrition policy experts, newly obtained documents show. By Nicholas Florko Popular nasal decongestant doesn't actually relieve congestion, FDA experts say FDA advisers voted unanimously on Tuesday against the effectiveness of the ingredient found in popular versions of Sudafed and Allegra. By Associated Press STAT+ | Nick Leschly departs Bluebird Bio spinout amid restructuring, layoffs The spinout, 2Seventy Bio, announced that it is cutting approximately 40% of its workforce, or about 176 employees. By Allison DeAngelis STAT+ | Here are the dozens of weight loss drugs in development to catch a booming market Our database tracks the new weight loss drugs that could hit the market, novel mechanisms, and which companies are in the hunt. By Elaine Chen and Allison DeAngelis and J. Emory Parker

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser